Literature DB >> 16855475

Divalproex versus placebo for the prevention of irritability associated with fluoxetine treatment in autism spectrum disorder.

Evdokia Anagnostou, Katherine Esposito, Latha Soorya, William Chaplin, Stacey Wasserman, Eric Hollander.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16855475     DOI： 10.1097/01.jcp.0000227703.72117.bc

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  8 in total

1.  Pharmacologic treatment of repetitive behaviors in autism spectrum disorders: evidence of publication bias.

Authors:  Melisa Carrasco; Fred R Volkmar; Michael H Bloch
Journal:  Pediatrics       Date:  2012-04-23       Impact factor: 7.124

Review 2.  Childhood epilepsy and autism spectrum disorders: psychiatric problems, phenotypic expression, and anticonvulsants.

Authors:  Sally J Robinson
Journal:  Neuropsychol Rev       Date:  2012-08-09       Impact factor: 7.444

Review 3.  An update on medication management of behavioral disorders in autism.

Authors:  Danielle A Baribeau; Evdokia Anagnostou
Journal:  Curr Psychiatry Rep       Date:  2014-03       Impact factor: 5.285

Review 4.  Antiepileptic medications in autism spectrum disorder: a systematic review and meta-analysis.

Authors:  Tomoya Hirota; Jeremy Veenstra-Vanderweele; Eric Hollander; Taro Kishi
Journal:  J Autism Dev Disord       Date:  2014-04

Review 5.  A perspective on molecular signalling dysfunction, its clinical relevance and therapeutics in autism spectrum disorder.

Authors:  Sushmitha S Purushotham; Neeharika M N Reddy; Michelle Ninochka D'Souza; Nilpawan Roy Choudhury; Anusa Ganguly; Niharika Gopalakrishna; Ravi Muddashetty; James P Clement
Journal:  Exp Brain Res       Date:  2022-09-05       Impact factor: 2.064

Review 6.  A review of traditional and novel treatments for seizures in autism spectrum disorder: findings from a systematic review and expert panel.

Authors:  Richard E Frye; Daniel Rossignol; Manuel F Casanova; Gregory L Brown; Victoria Martin; Stephen Edelson; Robert Coben; Jeffrey Lewine; John C Slattery; Chrystal Lau; Paul Hardy; S Hossein Fatemi; Timothy D Folsom; Derrick Macfabe; James B Adams
Journal:  Front Public Health       Date:  2013-09-13

Review 7.  Randomised controlled trials of mood stabilisers for people with autism spectrum disorder: systematic review and meta-analysis.

Authors:  Bharati Limbu; Shoumitro Deb; Meera Roy; Rachel Lee; Ashok Roy; Oluwafemi Taiwo
Journal:  BJPsych Open       Date:  2022-02-24

Review 8.  Current Enlightenment About Etiology and Pharmacological Treatment of Autism Spectrum Disorder.

Authors:  Nermin Eissa; Mohammed Al-Houqani; Adel Sadeq; Shreesh K Ojha; Astrid Sasse; Bassem Sadek
Journal:  Front Neurosci       Date:  2018-05-16       Impact factor: 4.677
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.